explore -WSS

explore

author：knowledge 2025-08-04 12:36:08 - browse：634

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： How to protect patients from sexual assault

WSS

Hyundai and Kia recall nearly 92,000 vehicles and tell owners to park them outside due to fire risk

AstraZeneca chief proposes a novel edit to the drug pricing bill

The high personal cost of affirmative action for Black doctors

The high personal cost of affirmative action for Black doctors

Vertex non

Why Novartis is changing the name of its research labs

hotspot

explore

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Wildfire pollution widens asthma inequities on Long Island

Psychedelics group wrestles with new pharma identity

Stem cell treatment guidelines are released by FDA

How one medical school became remarkably diverse

Stem cell treatment guidelines are released by FDA

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Infectious disease expert Jeanne Marrazzo assumes Fauci role

Supreme Court strikes down use of affirmative action

Breakthrough Alzheimer’s drugs are inaccessible in rural states

leisure time

What drug price negotiations mean for Medicare Part D

The (many) problems with a new study criticizing cancer screening

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

What drug price negotiations mean for Medicare Part D

Weighted lottery helped low

Mega Millions pot grows to $1.25 billion after no winner

focus

Wikipedia

focus

hotspot